As of 2025-04-23, the Intrinsic Value of Veritas Pharma Inc (VRT.CN) is - CAD. This VRT.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.11 CAD, the upside of Veritas Pharma Inc is -100.00%.
Based on its market price of 0.11 CAD and our intrinsic valuation, Veritas Pharma Inc (VRT.CN) is overvalued by 100.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | - - - | - | -100.00% |
| DDM - Stable | (0.35) - (1.75) | (1.05) | -1054.7% |
| DDM - Multi | (0.28) - (1.11) | (0.45) | -511.1% |
| Market Cap (mil) | 2.46 |
| Beta | -0.17 |
| Outstanding shares (mil) | 22.41 |
| Enterprise Value (mil) | 3.04 |
| Market risk premium | 4.74% |
| Cost of Equity | 7.89% |
| Cost of Debt | 5.00% |
| WACC | 7.78% |